Search
for
Sort by
Research 451–480 of 1000+
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk
- Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia
- Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: A case-control study
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Hutchinson-gilford progeria syndrome and its relevance to cardiovascular diseases and normal aging.
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- Cardiovascular risk markers in premature canities
- Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age
- Low dose oral minoxidil and the conundrum of cardiovascular complications
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Cardiac and Medullary Neuroinflammatory Pathways Trigger Androgenic Incitement of Cardiovascular Sequels of Endotoxemia in Rats
- CARDIOVASCULAR SAFETY OF LOW-DOSE ORAL MINOXIDIL FOR ANDROGENETIC ALOPECIA IN PATIENTS WITH HYPERTENSION OR ARRHYTHMIAS
- Comments on “ Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study ”
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Association between androgenetic alopecia and cardiovascular diseases: a genetic correlation and Mendelian randomization study
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- Supplementary file 2_Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.docx
- Supplementary file 1_Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.docx
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- KATP Channels in Zebrafish Cardiovascular System: A Model to Study Cantú Syndrome
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review